Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce rectal bleeding, persistent diarrhea, rectal pain, weight loss, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

Is your child currently experiencing moderate to severe UC flare-ups? Local research is testing a potential new medication to see if it may reduce urgency to defecate, iron deficiency, diarrhea, frequent fevers, and/or anemia associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

Is your child currently experiencing gastrointestinal disease flare-ups? Local medical research study is testing a potential new medication to see if it may reduce tiredness, fistula, diarrhea, frequent fevers, and/or canker sores associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for young people 2 to 17 years of age to join a CD clinical research to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or gastrointestinal disease (including associated symptoms such as weight loss, persistent diarrhea, cramps, weight loss and/or anemia), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing CD flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce rectal pain, iron deficiency, cramps, chronic fatigue, and/or liver disease associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for 2 to 17 years of age to join a Crohn’s disease research study to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or ulcerative colitis (UC) (including associated symptoms such as urgency to defecate, abdominal cramps, abdominal pain, weight loss and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for 2 to 17 years old to join a Crohn’s disease research study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s disease (CD) (including associated symptoms such as urgency to defecate, diarrhea, bloody stool, chronic fatigue and/or eye pain), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

We are looking for 2 to 17 years old to join a Crohn’s disease (CD) research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s and UC (including associated symptoms such as cramping, weight loss, bloody stool, weight loss and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for children 2–17 years of age to join a CD clinical trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s (including associated symptoms such as chronic diarrhea, iron deficiency, diarrhea, frequent fevers and/or liver disease), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing moderate to severe IBD flare-ups? Local clinical research is testing a potential new medication to see if it may reduce cramping, fatigue, bloody stool, chronic fatigue, and/or joint pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.